These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 23741368

  • 1. Sustained protection in mice immunized with fractional doses of Salmonella Enteritidis core and O polysaccharide-flagellin glycoconjugates.
    Simon R, Wang JY, Boyd MA, Tulapurkar ME, Ramachandran G, Tennant SM, Pasetti M, Galen JE, Levine MM.
    PLoS One; 2013; 8(5):e64680. PubMed ID: 23741368
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.
    Baliban SM, Curtis B, Toema D, Tennant SM, Levine MM, Pasetti MF, Simon R.
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006522. PubMed ID: 29791435
    [Abstract] [Full Text] [Related]

  • 3. Salmonella enterica serovar enteritidis core O polysaccharide conjugated to H:g,m flagellin as a candidate vaccine for protection against invasive infection with S. enteritidis.
    Simon R, Tennant SM, Wang JY, Schmidlein PJ, Lees A, Ernst RK, Pasetti MF, Galen JE, Levine MM.
    Infect Immun; 2011 Oct; 79(10):4240-9. PubMed ID: 21807909
    [Abstract] [Full Text] [Related]

  • 4. Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa.
    Baliban SM, Yang M, Ramachandran G, Curtis B, Shridhar S, Laufer RS, Wang JY, Van Druff J, Higginson EE, Hegerle N, Varney KM, Galen JE, Tennant SM, Lees A, MacKerell AD, Levine MM, Simon R.
    PLoS Negl Trop Dis; 2017 Apr; 11(4):e0005493. PubMed ID: 28388624
    [Abstract] [Full Text] [Related]

  • 5. Immunogenicity and protective efficacy against Salmonella C2-C3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein.
    Schuster O, Sears KT, Ramachandran G, Fuche FJ, Curtis B, Tennant SM, Simon R.
    Hum Vaccin Immunother; 2019 Apr; 15(6):1436-1444. PubMed ID: 29873578
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation.
    Baliban SM, Allen JC, Curtis B, Amin MN, Lees A, Rao RN, Naidu G, Venkatesan R, Rao DY, Mohan VK, Ella KM, Levine MM, Simon R.
    Molecules; 2018 Jul 17; 23(7):. PubMed ID: 30018230
    [Abstract] [Full Text] [Related]

  • 11. Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella.
    Ramachandran G, Tennant SM, Boyd MA, Wang JY, Tulapurkar ME, Pasetti MF, Levine MM, Simon R.
    PLoS One; 2016 Jul 17; 11(3):e0151875. PubMed ID: 26998925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L, Stefanetti G, Saul A, MacLennan CA, Micoli F, Rondini S.
    PLoS One; 2015 Jul 17; 10(10):e0139847. PubMed ID: 26445460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
    Micoli F, Rondini S, Alfini R, Lanzilao L, Necchi F, Negrea A, Rossi O, Brandt C, Clare S, Mastroeni P, Rappuoli R, Saul A, MacLennan CA.
    Proc Natl Acad Sci U S A; 2018 Oct 09; 115(41):10428-10433. PubMed ID: 30262653
    [Abstract] [Full Text] [Related]

  • 16. Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.
    Simon R, Levine MM.
    Hum Vaccin Immunother; 2012 Apr 09; 8(4):494-8. PubMed ID: 22370510
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of soluble recombinant FliC protein from Salmonella enterica serovar enteritidis as a potential vaccine candidate against homologous challenge in chickens.
    Okamura M, Matsumoto W, Seike F, Tanaka Y, Teratani C, Tozuka M, Kashimoto T, Takehara K, Nakamura M, Yoshikawa Y.
    Avian Dis; 2012 Jun 09; 56(2):354-8. PubMed ID: 22856193
    [Abstract] [Full Text] [Related]

  • 18. Protective ability of subcellular extracts from Salmonella Enteritidis and from a rough isogenic mutant against salmonellosis in mice.
    Ochoa-Repáraz J, García B, Solano C, Lasa I, Irache JM, Gamazo C.
    Vaccine; 2005 Feb 10; 23(12):1491-501. PubMed ID: 15670885
    [Abstract] [Full Text] [Related]

  • 19. Protection against oral challenge three months after i.v. immunization of BALB/c mice with live Aro Salmonella typhimurium and Salmonella enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen.
    Hormaeche CE, Mastroeni P, Harrison JA, Demarco de Hormaeche R, Svenson S, Stocker BA.
    Vaccine; 1996 Mar 10; 14(4):251-9. PubMed ID: 8744548
    [Abstract] [Full Text] [Related]

  • 20. Vaccination of chickens with SPI1-lon and SPI1-lon-fliC mutant of Salmonella enterica Serovar Enteritidis.
    Matulova M, Havlickova H, Sisak F, Rychlik I.
    PLoS One; 2013 Mar 10; 8(6):e66172. PubMed ID: 23785484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.